Polydopamine modified by pillar[5]arene in situ for targeted chemo-photothermal cancer therapy†
Abstract
A pillar[5]arene-modified polydopamine (PDA-P[5]OH) displaying pH/NIR dual-responsive properties was constructed successfully in situ for targeted chemo-photothermal cancer therapy.